BioPharmSignal logoBioPharmSignal

Biotech News

Biote Reports Third Quarter 2025 Financial Results

biote Corp (BTMD)biote Corp2026-06-25 13:46 ESTEarnings

Continued progress against strategic priorities Repurchased approximately one million shares of Class A common stock Reiterates 2025 financial guidance Third Quarter 2025 Financial Highlights Revenue of $48.0 million Gross profit margin of 71.8% Net income of $9.2 million and diluted earnings per

Open original release

Related news

BTMDbiote Corp2026-06-25 13:46 EST

Biote Appoints Komal Bajaj, MD, MS as Chief Medical Officer

BTMDbiote Corp2026-06-25 13:46 EST

Biote Names Bob Peterson, Current Chief Financial and Chief Business Officer, as Interim CEO

BTMDbiote Corp2026-06-25 13:46 EST

Biote Reports First Quarter 2026 Financial Results

BTMDbiote Corp2026-06-25 13:46 EST

Biote Reports First Quarter 2025 Financial Results

BTMDbiote Corp2026-06-25 13:46 EST

Biote Names Rich Barrera to Board of Directors

BTMDbiote Corp2026-06-25 13:46 EST

Biote Schedules Second Quarter 2025 Financial Results Release and Conference Call

BTMDbiote Corp2026-06-25 13:46 EST

Biote Reports Second Quarter 2025 Financial Results

BTMDbiote Corp2026-06-25 13:46 EST

Biote Schedules Third Quarter 2025 Financial Results Release and Conference Call

BTMDbiote Corp2026-06-25 13:46 EST

Nearly 40% of Women Say They were Misdiagnosed During Perimenopause, National Survey Reveals

BTMDbiote Corp2026-06-25 13:46 EST

Biote Schedules Fourth Quarter and Full Year 2025 Financial Results Release and Conference Call

View all latest news

biote Corp

biote is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

BTMDbiote Corp2026-06-26 12:43 EST

Biote Appoints Komal Bajaj, MD, MS as Chief Medical Officer

BTMDbiote Corp2026-06-26 12:43 EST

Biote Names Bob Peterson, Current Chief Financial and Chief Business Officer, as Interim CEO

BTMDbiote Corp2026-06-26 12:43 EST

Biote Reports First Quarter 2026 Financial Results

BTMDbiote Corp2026-06-26 12:43 EST

Biote Reports First Quarter 2025 Financial Results

BTMDbiote Corp2026-06-26 12:43 EST

Biote Names Rich Barrera to Board of Directors

Stock data

Close
—
Market cap
—
Exchange
NASDAQ
Sector
Biotechnology
Location
United States